Search bioRxivSearch

bioRxiv · 10.1101/456277

Deep Learning on MRI Affirms the Prominence of the Hippocampal Formation in Alzheimer’s Disease Classification

Abstract

Deep learning techniques on MRI scans have demonstrated great potential to improve the diagnosis of neurological diseases. Here, we investigate the application of 3D deep convolutional neural networks (CNNs) for classifying Alzheimers disease (AD) based on structural MRI data. In particular, we take on two challenges that are under-explored in the literature on deep learning for neuroimaging. First deep neural networks typically require large-scale data that is not always available in medical studies. Therefore, we explore the use of including longitudinal scans in classification studies, greatly increasing the amount of data for training and improving the generalization performance of our classifiers. Moreover, previous studies applying deep learning to classifying Alzheimers disease from neuroimaging have typically addressed classification based on whole brain volumes but stopped short of performing in-depth regional analyses to localize the most predictive areas. Additionally, we show a deep net trained to distinguish between AD and cognitively normal subjects can be applied to classify mild cognitive impairment patients, with classification scores aligning empirically with the likelihood of progression to AD. Our initial results demonstrate both that we can classify AD with an area under the receiver operator characteristic curve (AUROC) of .990 and that we can predict conversion to AD among patients in the MCI subgroup with an AURUC of 0.787. We then localize the predictive regions, by performing both saliency-based interpretation and rigorous slice and lobar level ablation studies. Interestingly, our regional analyses identified the hippocampal formation, including the entorhinal cortex, to be the most predictive region for our models. This finding adds evidence that the hippocampal formation is an anatomical seat of AD and a prominent feature in its diagnosis. Together, the results of this study further demonstrate the potential of deep learning to impact AD classification and to identify ADs structural neuroimaging signatures. The proposed classification and regional analyses methods constitute a general framework that can easily be applied to other disorders and imaging modalities.\n\nAcronyms

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Feng, X., Yang, J., Lipton, Z. C., Small, S. A., Provenzano, F. A.. 2018-10-31. Deep Learning on MRI Affirms the Prominence of the Hippocampal Formation in Alzheimer’s Disease Classification. https://doi.org/10.1101/456277

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience